Related Experiment Video
Updated: Jul 3, 2025

09:08
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
1.9K
Correction to: OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target
Michael Croft1, Ehsanollah Esfandiari2, Camilla Chong2
1Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA. mick@lji.org.
American Journal of Clinical Dermatology
|February 10, 2024
Abstract
No abstract available in PubMed .

